The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluation of chemokine-ligand pathways in pretreatment tumor biopsies as predictive biomarker of response to adoptive therapy in metastatic melanoma patients.
Davide Bedognetti
No relevant relationships to disclose
Sara Tomei
No relevant relationships to disclose
Tara L Spivey
No relevant relationships to disclose
Valeria De Giorgi
No relevant relationships to disclose
Maria Libera Ascierto
No relevant relationships to disclose
Ena Wang
No relevant relationships to disclose
Mark E. Dudley
No relevant relationships to disclose
Lorenzo Uccellini
No relevant relationships to disclose
Mario Roberto Sertoli
No relevant relationships to disclose
Francesco Marincola
No relevant relationships to disclose
Steven A. Rosenberg
No relevant relationships to disclose